Literature DB >> 18192871

Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.

Yutaka Suzuki1, Masanori Sugiyama, Nobutsugu Abe, Yasunori Fujioka, Yutaka Atomi.   

Abstract

OBJECTIVE: Pancreatic mucinous cystic tumor (MCT(P)) and ovarian mucinous cystic tumor (MCT(O)) show common features. However, there are few studies showing a comparison of both types of tumor. We immunohistochemically studied both types of tumor to clarify their characteristics.
METHODS: Eight patients with MCT(P) and 21 patients with MCT(O) were examined. The tumors were immunohistochemically examined using antibodies against female sex hormone receptors (estrogen receptor, progesterone receptor, and alpha-inhibin), pancreatobiliary tissue markers (carbohydrate antigen 19-9 and DUPAN2) and cell cycle regulators (p27kip1 and phosphorylated retinoblastoma). Samples from 7 female patients with invasive pancreatic ductal carcinoma (DC), 8 female patients with normal pancreatic tissue, and 10 patients with normal ovarian tissue were also examined.
RESULTS: In the tumor epithelial cells, the expressions of DUPAN2 and p27/kip1 were similar between MCT(P) (38% and 88%, respectively) and MCT(O) (14% and 76%, respectively), but significantly different between both tumors and DC (100% and 0%). In the stromal cells, the expressions of estrogen receptor, progesterone receptor, alpha-inhibin, and p27/kip1 were similar between MCT(P) (63%, 75%, 50%, and 63%, respectively) and MCT(O) (57%, 71%, 81%, and 57%, respectively), but significantly different between both tumors and DC (0%, 0%, 0%, and 0%, respectively).
CONCLUSIONS: MCT(P) and MCT(O) have several immunohistochemical similarities and are significantly different from DC. The female sex hormone system may play a major role in the development of both MCT(P) and MCT(O). A frequent p27/kip1 expression level was associated with nonaggressive progression of both tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192871     DOI: 10.1097/mpa.0b013e3181584643

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  4 in total

1.  Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis.

Authors:  Priyanka Singh; Laura M Jenkins; Ben Horst; Victoria Alers; Shrikant Pradhan; Prabhjot Kaur; Tapasya Srivastava; Nadine Hempel; Balázs Győrffy; Eugenia V Broude; Nam Y Lee; Karthikeyan Mythreye
Journal:  Cancer Res       Date:  2018-03-13       Impact factor: 12.701

Review 2.  Management of mucinous cystic neoplasms of the pancreas.

Authors:  Mario Testini; Angela Gurrado; Germana Lissidini; Pietro Venezia; Luigi Greco; Giuseppe Piccinni
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

3.  Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms.

Authors:  Akira Watanabe; Kenichiro Araki; Takehiko Yokobori; Bolag Altan; Norihiro Ishii; Mariko Tsukagoshi; Norio Kubo; Fumiyoshi Saito; Hideki Suzuki; Hiroyuki Kuwano
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

4.  Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.

Authors:  Kevin M Elias; Petros Tsantoulis; Jean-Christophe Tille; Allison Vitonis; Leona A Doyle; Jason L Hornick; Gurkan Kaya; Laurent Barnes; Daniel W Cramer; Giacomo Puppa; Sarah Stuckelberger; Jagmohan Hooda; Pierre-Yves Dietrich; Michael Goggins; Candace L Kerr; Michael Birrer; Michelle S Hirsch; Ronny Drapkin; Sana Intidhar Labidi-Galy
Journal:  J Pathol       Date:  2018-10-19       Impact factor: 7.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.